Why is Themis Medicare falling/rising?

As of 07-Jul, Themis Medicare Ltd is currently priced at 125.80, reflecting an increase of 0.85 or 0.68%. Today's price summary indicates that the stock has outperformed its sector by 0.76% and has experienced a trend reversal, gaining after four consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has seen a significant decline in investor participation, with delivery volume dropping by 34.47% compared to the 5-day average. Despite a low Debt to EBITDA ratio suggesting a strong ability to service debt, the company has faced challenges, including a 40.79% decline in returns over the past year and a 31.5% drop in profits, which may contribute to the stock's volatility.
In the broader market context, Themis Medicare's short-term performance has been notably poor, with a 3.71% decline over the past week, while the Sensex has only decreased by 0.20%. This underperformance is compounded by the company's negative financial results, including a 23.57% fall in net sales and negative results for the last two consecutive quarters. The stock's long-term growth prospects appear weak, as indicated by a 7.40% annual growth rate in operating profit over the last five years and a lack of domestic mutual fund investment, which may signal a lack of confidence in the stock's valuation. Overall, these factors suggest that while there may be a slight uptick in the stock price today, the underlying fundamentals remain concerning.